Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polly A Hofmann

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|September 18, 2002
Antiadrenergic effects of adenosine A(1) receptor-mediated protein phosphatase 2a activation in the heartQinghang Liu, Polly A Hofmann
American Journal of Physiology. Heart and Circulatory Physiology|February 14, 2004
Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytesQinghang Liu, Polly A Hofmann
American Journal of Physiology. Heart and Circulatory Physiology|March 22, 2003
Modulation of protein phosphatase 2a by adenosine A1 receptors in cardiomyocytes: role for p38 MAPKQinghang Liu, Polly A Hofmann
American Journal of Physiology. Heart and Circulatory Physiology|May 24, 2003
Cardioprotection through a PKC-dependent decrease in myofilament ATPaseW Glen Pyle, Yi Chen, Polly A Hofmann
American Journal of Physiology. Heart and Circulatory Physiology|May 24, 2005
Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heartRavi Rajashree, Bradford C Blunt, Polly A Hofmann
American Journal of Physiology. Heart and Circulatory Physiology|October 3, 2006
Acute modulation of PP2a and troponin I phosphorylation in ventricular myocytes: studies with a novel PP2a peptide inhibitorPrajwal A Deshmukh, Bradford C Blunt, Polly A Hofmann
The Journal of Pharmacology and Experimental Therapeutics|July 30, 2010
Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198)Chun Cai, Leonard Lothstein, R Ray Morrison, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 23, 2004
Modest actomyosin energy conservation increases myocardial postischemic functionBradford C Blunt, Yi Chen, James D Potter, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 15, 2003
Age-related functional effects linked to phosphatase activity in ventricular myocytesElizabeth M Grey, Chun K Chan, Yi Chen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 22, 2007
H2O2 activation of HSP25/27 protects desmin from calpain proteolysis in rat ventricular myocytesBradford C Blunt, Aaron T Creek, DeAnna C Henderson, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
American Journal of Physiology. Heart and Circulatory Physiology|September 18, 2002
Antiadrenergic effects of adenosine A(1) receptor-mediated protein phosphatase 2a activation in the heartQinghang Liu, Polly A Hofmann
American Journal of Physiology. Heart and Circulatory Physiology|February 14, 2004
Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytesQinghang Liu, Polly A Hofmann
American Journal of Physiology. Heart and Circulatory Physiology|March 22, 2003
Modulation of protein phosphatase 2a by adenosine A1 receptors in cardiomyocytes: role for p38 MAPKQinghang Liu, Polly A Hofmann
American Journal of Physiology. Heart and Circulatory Physiology|May 24, 2003
Cardioprotection through a PKC-dependent decrease in myofilament ATPaseW Glen Pyle, Yi Chen, Polly A Hofmann
American Journal of Physiology. Heart and Circulatory Physiology|May 24, 2005
Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heartRavi Rajashree, Bradford C Blunt, Polly A Hofmann
American Journal of Physiology. Heart and Circulatory Physiology|October 3, 2006
Acute modulation of PP2a and troponin I phosphorylation in ventricular myocytes: studies with a novel PP2a peptide inhibitorPrajwal A Deshmukh, Bradford C Blunt, Polly A Hofmann
The Journal of Pharmacology and Experimental Therapeutics|July 30, 2010
Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198)Chun Cai, Leonard Lothstein, R Ray Morrison, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 23, 2004
Modest actomyosin energy conservation increases myocardial postischemic functionBradford C Blunt, Yi Chen, James D Potter, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 15, 2003
Age-related functional effects linked to phosphatase activity in ventricular myocytesElizabeth M Grey, Chun K Chan, Yi Chen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 22, 2007
H2O2 activation of HSP25/27 protects desmin from calpain proteolysis in rat ventricular myocytesBradford C Blunt, Aaron T Creek, DeAnna C Henderson, et al.
Pageof 2